|
|
|
|
Vol. 12, Issue 12, 4030-4043, December 2001
6
4 Integrin:
Implications for Basement Membrane Organization and Tumor
Invasion


§ and
*Department of Pathology, Division of Cancer Biology and
Angiogenesis, Beth Israel Deaconess Medical Center, Boston,
Massachusetts 02115; §Schepens Eye Research Institute,
Boston, Massachusetts 02115; and The integrin
Harvard Medical School,
Boston, Massachusetts 02115
6
4, a laminin receptor that stabilizes
epithelial cell adhesion to the basement membrane (BM) through its
association with cytokeratins, can stimulate the formation and
stabilization of actin-rich protrusions in carcinoma cells. An
important, unresolved issue, however, is whether this integrin
can transmit forces to the substrate generated by the acto-myosin
system. Using a traction-force detection assay, we detected forces
exerted through
6
4 on either laminin-1 or on an anti-
6
antibody, demonstrating that this integrin can transmit forces
without the need to engage other integrins. These
6
4-dependent traction forces were organized into a compression machine localized to the base of lamellae. We hypothesized that the
compression forces generated by
6
4 result in the remodeling of
BMs because this integrin plays a major role in the interaction of epithelial and carcinoma cells with such structures. Indeed, we
observed that carcinoma cells are able to remodel a reconstituted BM
through
6
4-mediated compression forces by a process that involves
the packing of BM material under the cells and the mechanical removal
of BM from adjacent areas. The distinct signaling functions of
6
4, which activate phosphoinositide 3-OH kinase and RhoA, also contribute to remodeling. Importantly, we demonstrate remodeling of a native BM by epithelial cells and the involvement of
6
4 in
this remodeling. Our findings have important implications for the
mechanism of both BM organization and tumor invasion.
Online version of this article contains video
material for certain figures. Online version available at
www.molbiolcell.org.
Corresponding author. E-mail address:
irabinov{at}caregroup.harvard.edu.
This article has been cited by other articles:
![]() |
M. A. Stepp, Y. Liu, S. Pal-Ghosh, R. A. Jurjus, G. Tadvalkar, A. Sekaran, K. LoSicco, L. Jiang, M. Larsen, L. Li, et al. Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1 J. Cell Sci., August 15, 2007; 120(16): 2851 - 2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bonaccorsi, D. Nosi, M. Muratori, L. Formigli, G. Forti, and E. Baldi Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines J. Mol. Endocrinol., January 1, 2007; 38(1): 51 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Lee, S. Seng, H. Li, S. J. Kennel, H. K. Avraham, and S. Avraham Integrin Regulation by Vascular Endothelial Growth Factor in Human Brain Microvascular Endothelial Cells: ROLE OF {alpha}6beta1 INTEGRIN IN ANGIOGENESIS J. Biol. Chem., December 29, 2006; 281(52): 40450 - 40460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. U. Sehgal, P. J. DeBiase, S. Matzno, T.-L. Chew, J. N. Claiborne, S. B. Hopkinson, A. Russell, M. P. Marinkovich, and J. C. R. Jones Integrin beta4 Regulates Migratory Behavior of Keratinocytes by Determining Laminin-332 Organization J. Biol. Chem., November 17, 2006; 281(46): 35487 - 35498. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gleason, B. Adley, M. S. Rao, and L. K. Diaz Immunohistochemical Detection of the {beta}4 Integrin Subunit in Pancreatic Adenocarcinoma J. Histochem. Cytochem., June 1, 2005; 53(6): 799 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzocca, R. Coppari, R. De Franco, J.-Y. Cho, T. A. Libermann, M. Pinzani, and A. Toker A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions Cancer Res., June 1, 2005; 65(11): 4728 - 4738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pal-Ghosh, A. Pajoohesh-Ganji, M. Brown, and M. A. Stepp A Mouse Model for the Study of Recurrent Corneal Epithelial Erosions: {alpha}9{beta}1 Integrin Implicated in Progression of the Disease Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1775 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Diaz, X. Zhou, K. Welch, A. Sahin, and M. Z. Gilcrease Chromogenic In Situ Hybridization for {alpha}6{beta}4 Integrin in Breast Cancer: Correlation with Protein Expression J. Mol. Diagn., February 1, 2004; 6(1): 10 - 15. [Abstract] [Full Text] |
||||
![]() |
C. Yang, M. Zeisberg, J. C. Lively, P. Nyberg, N. Afdhal, and R. Kalluri Integrin {alpha}1{beta}1 and {alpha}2{beta}1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment Cancer Res., December 1, 2003; 63(23): 8312 - 8317. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Baldi, L. Bonaccorsi, and G. Forti Androgen Receptor: Good Guy or Bad Guy in Prostate Cancer Invasion? Endocrinology, May 1, 2003; 144(5): 1653 - 1655. [Full Text] [PDF] |
||||
![]() |
M. Katayama, N. Sanzen, A. Funakoshi, and K. Sekiguchi Laminin {gamma}2-Chain Fragment in the Circulation: A Prognostic Indicator of Epithelial Tumor Invasion Cancer Res., January 1, 2003; 63(1): 222 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Kazarov, X. Yang, C. S. Stipp, B. Sehgal, and M. E. Hemler An extracellular site on tetraspanin CD151 determines {alpha}3 and {alpha}6 integrin-dependent cellular morphology J. Cell Biol., September 29, 2002; 158(7): 1299 - 1309. [Abstract] [Full Text] [PDF] |
||||